Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disease of the bladder along with pain and frequent and urgent urination. Chronic inflammation of the bladder is accompanied by the infiltration of macrophages, lymphocytes, mast cells and plasma cells to the bladder wall, which leads to irreversible changes in its tissues (
1-
3). The nature of IC/BPS is still not fully understood. Autoimmune, allergic, infectious, neurological, and vascular diseases, as well as increased infiltration of mast cells to the bladder wall, damage to mucin protective layer and the exposure of the bladder wall to the toxic substances found in the urine are among etiological factors. A variety of symptoms and differences in the susceptibility of patients to the treatment reveal the multi-etiological nature of the disease (
4,
5).
Different degrees of severity of inflammation are detected in the biopsy specimens of the bladder; however, cellular mechanisms of inflammation in IC/BPS and the processes leading to tissue damage and fibrosis are not yet clear (
6, 7). Among many suggested causes, mast cell activation is noteworthy (
8). There is an increase in the number of mast cells and their infiltration to the bladder wall (
8). Various models of cystitis in rodents showed an increased number of mast cells and their activation (
9,
10). However, owing to the limited number of published studies in this regard, currently available evidence remains limited. Although most researchers have declared certain results, emphasize the complexity of the disease and the need for further research. Because of the complexity of the pathophysiology of IC/BPS, a number of animal models are used to better understand the underlying mechanisms of this disease. Modeling is often created by the intravesical instillation of protamine sulfate, the introduction of cyclophosphamide, etc. (
11,
12). More than two decades, animal models with autoimmune inflammation of the bladder have been actively used in IC/BPS research (
13,
14). Animal model research has shown that mast cells are responsible for bladder inflammation and pain in various models (
13). However, despite this research, the role of mast cells associated with cystitis has not been identified clearly.
The data of histopathology of the bladder revealed the role of cell-mediated immunity in IC/BPS, which does not exclude the possibility that autoimmune inflammation is probably a component of pathophysiology in patients with this disease (
7). Although mast cells are characteristic features of this disease, there is no consensus on their specificity and diagnostic significance. Transmural fibrosis can develop in the terminal stage of the disease, which leads to wrinkling of the bladder. The main task of a biopsy is not exactly the diagnosis of this disease, but it helps the detection of carcinoma in situ, which can mask interstitial cystitis.